TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 SEK)
| Closing information | 2025/09 | 2024/09 | 2023/09 |
| Turnover |
5,157
|
5,847
|
6,610 |
| Financial expenses |
27
|
0
|
0 |
| Earnings before taxes |
3,412
|
4,135
|
4,589 |
| EBITDA |
3,415
|
3,692
|
4,187 |
| Total assets |
26,471
|
25,384
|
22,237 |
| Current assets |
3,032
|
2,810
|
8,664 |
| Current liabilities |
1,232
|
2,507
|
2,862 |
| Equity capital |
24,489
|
22,322
|
19,045 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Solvency |
92.5%
|
87.9%
|
85.6% |
| Turnover per employee |
2,578
|
2,924
|
3,305 |
| Profit as a percentage of turnover |
66.2%
|
70.7%
|
69.4% |
| Return on assets (ROA) |
13.0%
|
16.3%
|
20.6% |
| Current ratio |
246.1%
|
112.1%
|
302.7% |
| Return on equity (ROE) |
13.9%
|
18.5%
|
24.1% |
| Change turnover |
-690
|
-763
|
503 |
| Change turnover % |
-12%
|
-12%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.